- IHH Healthcare's 1Q23 results came in within expectations. Operating performances were generally better across its operating companies, but was partially dragged by higher depreciation and interest expenses, as well as a higher effective tax rate.
- - Read this at SGinvestors.io -
IHH's 1Q23 within expectations
- Stripping out disposal gains on its assets and other adjustments, IHH Healthcare (SGX:Q0F)'s 1Q23 core PATMI fell by 19% y-o-y to MYR330m, accounting for 21% of ours and 19% of consensus’ full-year estimates. This is in-line, as we believe subsequent quarters could be stronger as patient volumes in Singapore recover as the COVID-19 situation improves, while IHH Healthcare could also benefit from the recent disposal of loss-making Gleneagles Chengdu.
- - Read this at SGinvestors.io -
COVID-19 impact lingers for Singapore ops
- Read more at SGinvestors.io.
Above is the excerpt from report by Maybank Research.
Clients of Maybank Securities may be the first to access the full report in PDF @ https://www.ketrade.com.sg/.
Shafiq Kadir Maybank Research | https://www.maybank-ke.com.sg/ 2023-06-01
Previous report by Maybank:
2022-02-24 IHH Healthcare - A Commendable FY21.
Price targets by 3 other brokers at IHH Healthcare Target Prices.
Listing of research reports at IHH Healthcare Analyst Reports.
Relevant links:
IHH Healthcare Share Price History,
IHH Healthcare Announcements,
IHH Healthcare Dividends & Corporate Actions,
IHH Healthcare News Articles
